Table 3

Comparison of sleepiness and measurements of sleep in patients with chronic heart failure with and without sleep-disordered breathing

No SDB (n=96)SDB (n=77)p Value
Epworth score7 (4–10)7 (5–10)0.45
OSLER duration (min)40 (39–40)40 (27–40)0.18
HADS score12 (6–17)11 (6–16)0.78
Total sleep time (min)355 (285–401)351 (295–408)0.55
Stage 1 sleep (% TST)25 (14–42)32 (21–48)0.02
Stage 2 sleep (% TST)39 (27–52)38 (21–46)0.15
Deep sleep (% TST)11 (6–18)10 (6–17)0.73
REM sleep (% TST)19 (15–25)17 (13–24)0.41
Sleep efficiency (%)69 (61–80)74 (63–81)0.26
Arousal index (events/h)16 (13–22)24 (19–36)<0.001
AHI (events/h)7.6 (4.1–11.0)27.0 (19.2–40.6)
Time SpO2 <90% (% TST)1.1 (0.1–19.8)8.3 (1.8–22.7)<0.001
Baseline SpO2 (%)93 (91–95)94 (92–95)0.62
3% ODI* (events/h)9.1 (6.2–13.0)24.4 (17.9–37.7)<0.001
Periodic limb movement index (events/h)14 (2–33)11 (3–42)0.78
  • Data are presented as median (IQR).

  • * 3% ODI measured from wrist worn pulse oximeter.

  • AHI, apnoea-hypopnoea index; HADS, Hospital Anxiety and Depression score; ODI, oxygen desaturation index; OSLER, Oxford Sleep Resistance Test; REM, rapid eye movement; SpO2, oxygen saturation; TST, total sleep time.